{"title": "PDF", "author": "PDF", "url": "media.dav-medien.de/toc/9783804740211_i.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "Inhaltsverzeichnis VII\nInhaltsverzeichnis\nVorwort   .......................................................................................................................................................  V\nAbk\u00fcrzungsverzeichnis   .......................................................................................................................  XXXI\nTEIL A  EINF\u00dcHRUNG\n1   Anthroposophische Medizin \u2013 Grundlagen und  \nintegratives Konzept   .......................................................................................  3\n1.1   Anthroposophie und Wissenschaft   ...................................................................  4\n1.2   Anthroposophische Medizin   ..................................................................................  5\n1.3   Die funktionelle Dreigliederung des Menschen:  \nBasiskonzept der anthroposophischen Psychosomatik   .....................  6\n1.4   Die heilende Beziehung von Mensch und Natur   ....................................  7\n1.5   Die vier Wesensglieder: Fundament der anthroposophischen \nAnthropologie   ..................................................................................................................  8\n1.5.1   Was Form und Gestalt gibt: der Physische Leib   ...........................................  8\n1.5.2   Die funktionellen Lebens- und Wachstumsprozesse:  \nder \u00c4therleib   ......................................................................................................................  8\n1.5.3   Empfindung, Bewegung, Bewusstsein: der Astralleib   ............................  9\n1.5.4   Selbstbewusstsein, Empathie, Verantwortung:  \ndie Ich-Organisation   .....................................................................................................  9\n1.6   Anthroposophische Arzneimittel mit Blick auf die funktionelle \n Dreigliederung  und die Wesensglieder des Menschen   ......................  10\n1.7   F\u00f6rderung von Patientenkompetenz   ...............................................................  12\n2   Grundlagen Anthroposophischer Pharmazie   .............................  15\n2.1   Pharmazeutische Prozesse   ......................................................................................  16\n2.1.1   W\u00e4rmeprozesse   .................................................................................................................  16\n2.1.2   Rhythmische pharmazeutische Verfahren  .......................................................  19\n2.1.3   Metallprozesse  ...................................................................................................................  20\n2.1.4   Typenmittel oder Arzneimittel f\u00fcr typische Krankheiten   .......................  22\n2.2   Darreichungsformen   ....................................................................................................  22\n2.3   Wirksamkeit und rechtliche Situation   ............................................................  23\n2.3.1   Wirksamkeit   ........................................................................................................................  23\n2.3.2   Zulassung und Registrierung   ...................................................................................  23\n2.4   Die Bedeutung der Naturstoffe und deren Qualit\u00e4t f\u00fcr die  \n Herstellung anthroposophischer Arzneimittel   .........................................  25\n2.4.1   Naturstoffe und ihre Beziehung zum Menschen   .........................................  25Inhaltsverzeichnis VIII\n2.4.2   Minerale, Erze, Metalle   ................................................................................................  28\n2.4.3   Rohstoffe tierischen Ursprungs   ..............................................................................  29\n2.4.4   Die Integration von \u00d6komanagement und nachhaltigem  \nWirtschaften   .......................................................................................................................  29\n2.5   Verb\u00e4nde   ..............................................................................................................................  30\n2.5.1   International Association of Anthroposophic Pharmacists (IAAP)   .... 30\n2.5.2   Gesellschaft f\u00fcr Anthroposophische Pharmazie in Deutschland e. V. \n(GAPiD)   ....................................................................................................................................  31\n3   Methodik der Arzneimittelfindung   .....................................................  33\n3.1   Arzneimittelfindung am Beispiel chronische Polyarthritis \n(chronisches Gelenkrheuma)  .................................................................................  34\n3.1.1   Pathogenese   .......................................................................................................................  34\n3.1.2   Polare Konstitutionstypen   .........................................................................................  35\n3.1.3   Interaktionelle Therapie: Neuordnung der dynamischen Resonanz  \nder Wesensglieder   ...........................................................................................................  35\n3.1.4   Tierische Arzneimittel   ...................................................................................................  36\n3.1.5   Winterbl\u00fchende Pflanzen zur Anregung von Atmungs-  \nund W\u00e4rmerhythmik   .....................................................................................................  40\n3.1.6   Potenzierte Giftpflanzen   ............................................................................................  43\n3.1.7   Mineralische Heilmittel Kalium carbonicum/Pottasche   ..........................  46\n3.1.8   \u00c4u\u00dfere Anwendungen, B\u00e4der-/\u00d6l- und Salbenanwendungen   .........  49\n3.1.9   Begleitende therapeutische Ma\u00dfnahmen   .......................................................  50\n3.1.10   Einsatz konventioneller Pharmaka   ......................................................................  51\n3.2   Arzneimittelfindung am Beispiel Multiple Sklerose   .............................  55\n3.2.1   Leitgedanke   ........................................................................................................................  55\n3.2.2   Grundgesten der Krankheitsdisposition im zentralen  Nervensystem   56\n3.2.3   Zum Krankheitsbild der Multiplen Sklerose   ....................................................  57\n3.2.4   Pathogenese und \u00c4tiologie   .......................................................................................  59\n3.2.5   Konventionelle Therapie im akuten Schub   .....................................................  61\n3.2.6   Anthroposophische Behandlung als Schubtherapie   .................................  64\n3.2.7   Anthroposophische Dauerbehandlung   .............................................................  66\n3.2.8   Symptomatische Therapie   ..........................................................................................  72\n3.2.9   Nichtmedikament\u00f6se Therapieans\u00e4tze   .............................................................  74\nTEIL B  KRANKHEITSBILDER\n4   Kopf   ...............................................................................................................................  81\n4.1   Gleichgewichtsorgan   ...................................................................................................  82\n4.1.1   Akuter Schwindel, zentral bedingt   .......................................................................  82\n4.1.2   Morbus Meni\u00e8re bzw. Meni\u00e8riformen-Symptomenkomplex  ...............  82InhaltsverzeichnisInhaltsverzeichnis IX\n4.1.3   Vestibul\u00e4re Migr\u00e4ne   .......................................................................................................  83\n4.1.4   Akuter Vestibularisausfall   ...........................................................................................  83\n4.1.5   Kinetosen   .............................................................................................................................  84\n4.1.6   Vertebragener Schwindel   ...........................................................................................  84\n4.1.7   Benigner Paroxysmaler Lagerungsschwindel (BPLS)   .................................  85\n4.1.8   Phobischer Schwankschwindel   ..............................................................................  85\n4.1.9   Schwindel bei Kindern und Jugendlichen   ......................................................  85\n4.1.10   Altersschwindel   ................................................................................................................  86\n5   ZNS   ..................................................................................................................................  88\n5.1   Multiple Sklerose   ............................................................................................................  89\n5.1.1   Allgemeine Therapie  ......................................................................................................  89\n5.1.2   Therapie beim akuten Schub   ...................................................................................  90\n5.1.3   Anthroposophische Schubtherapie   ......................................................................  90\n5.1.4   Anthroposophische Dauerbehandlung   .............................................................  91\n5.1.5   Symptomatische Therapie   ..........................................................................................  93\n6   Nerven   .........................................................................................................................  94\n6.1   Ischialgie   ..............................................................................................................................  95\n6.1.1   Medikament\u00f6se Therapie   ...........................................................................................  96\n6.1.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  96\n6.1.3   Lagerung, Krankengymnastik und Heileurythmie   .....................................  97\n6.2   Morbus Parkinson   ..........................................................................................................  97\n6.2.1   Medikament\u00f6se Therapie   ...........................................................................................  98\n6.2.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  99\n6.2.3   Nichtmedikament\u00f6se Therapie  ...............................................................................  99\n7   Augen   ...........................................................................................................................  101\n7.1   Glaukom   ...............................................................................................................................  103\n7.1.2   Akutes Winkelblockglaukom   ....................................................................................  104\n7.1.3   Engwinkelglaukom   .........................................................................................................  104\n7.1.4   Chronisches Weitwinkelglaukom   ..........................................................................  105\n7.1.5   Normaldruckglaukome   ................................................................................................  105\n7.1.6   Sekund\u00e4rglaukome   ........................................................................................................  105\n7.1.7   Medikament\u00f6se Begleittherapie   ...........................................................................  105\n7.2   Ablatio retinae, Netzhautabl\u00f6sung   ..................................................................  106\n7.2.1   Medikament\u00f6se Therapie   ...........................................................................................  106\n7.3   Amblyopie, Schwachsichtigkeit   ...........................................................................  107\n7.3.1   Medikament\u00f6se Therapie   ...........................................................................................  107\n7.4   Asthenopie, Sehschw\u00e4che   .......................................................................................  107\n7.4.1   Medikament\u00f6se Therapie   ...........................................................................................  108Inhaltsverzeichnis X\n7.5   Astigmatismus und Keratokonus, Hornhautverkr\u00fcmmung   ............  108\n7.5.1   Medikament\u00f6se Therapie   ...........................................................................................  108\n7.6   Blepharitis, Lidrandentz\u00fcndung   ........................................................................  109\n7.6.1   Medikament\u00f6se Therapie   ...........................................................................................  109\n7.7   Blepharospasmus, Lidzucken   ...............................................................................  110\n7.7.1   Medikament\u00f6se Therapie   ...........................................................................................  110\n7.8   Chalazion, Hagelkorn   ..................................................................................................  110\n7.8.1   Medikament\u00f6se Therapie   ...........................................................................................  110\n7.9   Chemosis, Bindehaut\u00f6dem   ....................................................................................  111\n7.9.1   Medikament\u00f6se Therapie   ...........................................................................................  111\n7.10   Ciliarneuralgie, Ciliarmuskelkrampf   .................................................................  111\n7.10.1   Medikament\u00f6se Therapie   ...........................................................................................  111\n7.11   Konjunktivitis, Bindehautentz\u00fcndung   ..........................................................  111\n7.11.1   Conjunctivitis allergica   .................................................................................................  111\n7.11.2   Eitrige Konjunktivitis, Conjunctivitis purulenta   ...........................................  112\n7.11.3   Katharralische Konjunktivitis, Erk\u00e4ltungskonjunktivitis   ........................  113\n7.11.4   Trockene Konjunktivitis, Conjuntivitis sicca   ...................................................  113\n7.11.5   Konjunktivitis durch gestaute Gef\u00e4\u00dfe   ...............................................................  113\n7.11.6   Conjunctivitis epidemica   ............................................................................................  114\n7.12   Contusio bulbi, Augenprellung   ............................................................................  114\n7.12.1   Medikament\u00f6se Therapie   ...........................................................................................  114\n7.13   Dacryocystitis, Tr\u00e4nensackentz\u00fcndung   ..........................................................  114\n7.13.1   Medikament\u00f6se Therapie   ...........................................................................................  115\n7.14   Episkleritis, Skleritis, Lederhautentz\u00fcndung   ............................................  115\n7.14.1   Medikament\u00f6se Therapie   ...........................................................................................  115\n7.15   Glask\u00f6rperblutung   ........................................................................................................  116\n7.15.1   Medikament\u00f6se Therapie   ...........................................................................................  116\n7.16   Glask\u00f6rpertr\u00fcbungen, Corpustr\u00fcbungen, Mouches volantes   ........  116\n7.16.1   Medikament\u00f6se Therapie   ...........................................................................................  116\n7.17   Hordeolum, Gerstenkorn   .........................................................................................  117\n7.17.1   Medikament\u00f6se Therapie   ...........................................................................................  117\n7.18   Hypermetropie, Hyperopie oder Weitsichtigkeit   .....................................  118\n7.19   Hyposphagma, Bindehautbluterguss, Konjunktivalblutung   .........  118\n7.20   Iritis, Cyclitis, Uveitis, Regenbogenhautentz\u00fcndung, \n Ciliark\u00f6rperentz\u00fcndung   ............................................................................................  119\n7.20.1   Medikament\u00f6se Therapie   ...........................................................................................  119Inhaltsverzeichnis XI\n7.21   Katarakt, Grauer Star, Linsentr\u00fcbung   .............................................................  121\n7.21.1   Medikament\u00f6se Therapie   ...........................................................................................  121\n7.22   Keratitis, Hornhautentz\u00fcndung   ..........................................................................  122\n7.22.1   Medikament\u00f6se Therapie   ...........................................................................................  122\n7.23   Lid\u00f6dem, Lidschwellung   ..........................................................................................  123\n7.24   Maculae corneae, Hornhauttr\u00fcbungen   .........................................................  123\n7.25   Makuladegeneration, Makulopathie   ...............................................................  124\n7.25.1   Medikament\u00f6se Therapie   ...........................................................................................  124\n7.26   Migraine ophtalmique, Augenmigr\u00e4ne, Photopsien   ...........................  124\n7.27   Myopia oder Kurzsichtigkeit   ...................................................................................  125\n7.27.1   Medikament\u00f6se Therapie   ...........................................................................................  125\n7.28   Netzhautblutungen   ......................................................................................................  125\n7.28.1   Medikament\u00f6se Therapie   ...........................................................................................  126\n7.29   Netzhautvenenthrombose   ......................................................................................  126\n7.30   Neuritis nervi optici, Papillitis, Neuritis retrobulbaris, \n Optikusatrophie, Sehnervatrophie, Sehnerventz\u00fcndung, \nOptikusneuritis   ................................................................................................................  126\n7.30.1   Medikament\u00f6se Therapie   ...........................................................................................  127\n7.31   Orbitalneuralgie   .............................................................................................................  127\n7.32   Phlykt\u00e4nen   .........................................................................................................................  127\n7.33   Photophobie, Licht\u00fcberempfindlichkeit   ......................................................  128\n7.34   Pterygium, Fl\u00fcgelfell   ...................................................................................................  128\n7.35   Ptosis palpebrae, Augenmuskelparesen   .......................................................  128\n7.36   Retinitis, Chorioretinitis, Retinochorioiditis centralis serosa, \n Netzhautentz\u00fcndung, Aderhautentz\u00fcndung   ...........................................  128\n7.37   Retinopathia angiospastica   ...................................................................................  129\n7.38   Retinopathia hypertonica   .......................................................................................  129\n7.39   Retinopathia diabetica   ..............................................................................................  129\n7.40   Strabismus convergens und divergens oder Schielen   .........................  130\n7.40.1   Medikament\u00f6se Therapie   ...........................................................................................  130\n7.41   Ver\u00e4tzung der Horn- und Bindehaut   ..............................................................  131\n8   Ohr   ..................................................................................................................................  133\n8.1   Mittelohrentz\u00fcndung   .................................................................................................  135\n8.1.1   Allgemeine Therapie  ......................................................................................................  135\n8.1.2   Akute Entz\u00fcndung   ..........................................................................................................  136Inhaltsverzeichnis XII\n8.1.3   Tubenkatarrh   ......................................................................................................................  136\n8.1.4   Persistierende Bel\u00fcftungsst\u00f6rung   ........................................................................  137\n8.2   Entz\u00fcndungen des Ohrs   ............................................................................................  137\n8.2.1   Chronische Ohrentz\u00fcndungen   ................................................................................  137\n8.2.2   Chronische Mittelohrentz\u00fcndungen   ...................................................................  140\n8.3   H\u00f6rst\u00f6rungen   ....................................................................................................................  141\n8.3.1   Schallleitungsst\u00f6rungen   .............................................................................................  141\n8.3.2   Otosklerose   ..........................................................................................................................  141\n8.4   Innenohrst\u00f6rung   ............................................................................................................  142\n8.4.1   H\u00f6rsturz   .................................................................................................................................  142\n8.4.2   Hyperakusis   .........................................................................................................................  143\n8.4.3   Tinnitus   ..................................................................................................................................  144\n8.4.4   Altersschwerh\u00f6rigkeit   ...................................................................................................  145\n9   Mund   ............................................................................................................................  147\n9.1   Stomatitis bzw. Gingivostomatitis herpetica   ............................................  148\n9.2   Mundschleimhautentz\u00fcndungen   ......................................................................  148\n9.2.1   Stomatitis aphtosa und herpetica   ........................................................................  149\n9.2.2   Soor oder Candidiasis   ...................................................................................................  150\n9.2.3   Morbus Beh\u00e7et   ..................................................................................................................  150\n9.2.4   Lichen ruber mucosus   ..................................................................................................  151\n9.2.5   Leukoplakie   .........................................................................................................................  151\n9.3   Speicheldr\u00fcsenerkrankungen  ...............................................................................  152\n9.3.1   Sialadentitis   ........................................................................................................................  152\n9.3.2   Parotitis epidemica (Mumps)   ...................................................................................  153\n9.3.3   Sialolithiasis   .......................................................................................................................  153\n9.3.4   Sialadenosen   ......................................................................................................................  153\n9.3.5   Geschmacksst\u00f6rungen   .................................................................................................  153\n9.4   Parotismischtumor (pleomorphes Adenom) und Karzinom der \nGlandula Parotis   .............................................................................................................  154\n10   Z\u00e4hne   ...........................................................................................................................  156\n10.1   Zahnbildung   ......................................................................................................................  158\n10.1.1   Medikament\u00f6se Unterst\u00fctzung/Therapie   .........................................................  158\n10.2   Dentitionsbeschwerden   ............................................................................................  159\n10.2.1   Medikament\u00f6se Unterst\u00fctzung/Therapie   .........................................................  159\n10.3   Versp\u00e4teter Zahnwechsel   .........................................................................................  160\n10.4   Z\u00e4hneknirschen, Bruxismus  ...................................................................................  160\n10.4.1   Medikament\u00f6se Unterst\u00fctzung/Therapie   .........................................................  160Inhaltsverzeichnis XIII\n10.5   Beschwerden im Trigeminusbereich   ................................................................  161\n10.5.1   Medikament\u00f6se Therapie   ...........................................................................................  161\n10.6   Parodontitis   .......................................................................................................................  161\n10.6.1   Akute Parodontitis hochentz\u00fcndlich   ..................................................................  162\n10.6.2   Chronische Parodontitis ohne Entz\u00fcndungsanzeichen  \n(fr\u00fcher: Parodontose)   ...................................................................................................  162\n10.6.3   Juvenile Parodontitis   ....................................................................................................  162\n10.7   Er\u00f6ffnete Kieferh\u00f6hle   .................................................................................................  162\n10.8   Er\u00f6ffnete Pulpa   ................................................................................................................  162\n10.9   Akute Pulpitis   ...................................................................................................................  163\n10.10   Kiefergelenksprobleme: Knacken, Schmerzen, auch bei \n Z\u00e4hneknirschen   ..............................................................................................................  163\n11   Nase   ...............................................................................................................................  165\n11.1   Akuter Schnupfen   ..........................................................................................................  166\n11.2   Trockene Nasenschleimhaut   ..................................................................................  166\n11.3   Chronisch rezidivierende Rhinitis   ......................................................................  167\n11.4   Akute und chronische Sinusitis   ...........................................................................  169\n11.4.1   Basistherapie   .....................................................................................................................  169\n11.4.2   Akute Sinusitis   ...................................................................................................................  169\n11.4.3   Chronische bzw. rezidivierende Sinusitis  .........................................................  170\n11.5   Nasenatmungsbehinderung   ..................................................................................  172\n11.5.1   Rhinopathia vasomotorica   ........................................................................................  172\n11.5.2   Rhinopathia allergica, Seasonal Allergic Rhinitis (SAR),   \nHeuschnupfen, Pollinose   ...........................................................................................  173\n11.5.3   Chronische polyp\u00f6se Rhinopathie   ........................................................................  174\n11.6   Riechst\u00f6rungen   ...............................................................................................................  175\n12   Rachen   ........................................................................................................................  176\n12.1   Chronische Tonsillitis   ..................................................................................................  177\n12.2   Hyperplasie der Rachenmandel (adenoide Vegetation) und  \nTonsillenhyperplasie   ...................................................................................................  178\n12.3   Monozytenangina (Pfeiffer'sches Dr\u00fcsenfieber)   .....................................  179\n12.4   Akute Pharyngitis   ..........................................................................................................  179\n12.5   Pharyngitis sicca   .............................................................................................................  180\n12.6   Mundbodenkarzinom, Zungengrundkarzinom und  \nTonsillenkarzinom   .........................................................................................................  181Inhaltsverzeichnis XIV\n12.7   Lymphadenitis colli   ......................................................................................................  181\n12.7.1   Medikament\u00f6se Therapie   ...........................................................................................  182\n12.7.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  182\n13   Schilddr\u00fcse   ..............................................................................................................  184\n13.1   Struma diffusa und Struma nodosa   .................................................................  186\n13.1.1   Medikament\u00f6se Therapie   ...........................................................................................  187\n13.2   Chronische lymphozyt\u00e4re Thyreoiditis Hashimoto   ................................  190\n13.2.1   Krankheitsmanifestation im dreigliedrigen Organismus   .......................  190\n13.2.2   Silent Thyreoiditis   ............................................................................................................  190\n13.2.3   Postpartale Thyreoiditis  ...............................................................................................  191\n13.2.4   Medikament\u00f6se Therapie   ...........................................................................................  191\n13.3   Morbus Basedow   ............................................................................................................  194\n13.3.1   Medikament\u00f6se Therapie   ...........................................................................................  194\n13.4   Subakute Thyreoiditis de Quervain   ...................................................................  197\n13.4.1   Medikament\u00f6se Therapie   ...........................................................................................  198\n13.5   Schilddr\u00fcsenkarzinom   ...............................................................................................  198\n13.5.1   Medikament\u00f6se Therapie   ...........................................................................................  199\n14   Kehlkopf   ....................................................................................................................  202\n14.1   Akute und stenosierende Laryngitis   ................................................................  203\n14.1.1   \u00c4u\u00dfere Anwendungen   .................................................................................................  203\n14.1.2   Perorale Therapie  .............................................................................................................  203\n14.1.3   Inhalationstherapie   .......................................................................................................  203\n14.2   Rezidivierende Laryngitis   ........................................................................................  203\n15   Bronchien   .................................................................................................................  204\n15.1   Akute Bronchitis   .............................................................................................................  205\n15.1.1   Symptomatik   ......................................................................................................................  205\n15.1.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  205\n15.1.3   Perorale Therapie  .............................................................................................................  206\n15.1.4   Parenterale Therapie   .....................................................................................................  206\n15.2   Tracheobronchitis   ..........................................................................................................  206\n15.2.1   Parenterale Therapie   .....................................................................................................  206\n15.3   Fiebrig schmerzhafte Bronchitis/Bronchopneumonie   ........................  207\n15.3.1   Inhalationstherapie   .......................................................................................................  207\n15.3.2   Perorale Therapie  .............................................................................................................  207\n15.3.3   Parenterale Therapie   .....................................................................................................  207Inhaltsverzeichnis XV\n15.4   Akute und obstruktive Bronchitis   ......................................................................  207\n15.4.1   Perorale Therapie  .............................................................................................................  207\n15.4.2   Parenterale Therapie   .....................................................................................................  208\n15.5   Chronische Bronchitis   .................................................................................................  208\n15.5.1   \u00c4u\u00dfere Anwendungen   .................................................................................................  208\n15.5.2   Massage und \u00fcbende Therapien   ...........................................................................  208\n15.5.3   Perorale, parenterale und Inhalationstherapie   ...........................................  208\n15.6   Chronische Emphysem-Bronchitis   ....................................................................  209\n15.7   Asthma bronchiale   .......................................................................................................  209\n15.7.1   Asthma bronchiale in der Kinderheilkunde  ...................................................  209\n15.7.2   Allgemeine Therapie  ......................................................................................................  210\n15.7.3   Akuttherapie   .......................................................................................................................  210\n15.7.4   Basistherapie   .....................................................................................................................  211\n15.7.5   Erg\u00e4nzende Aspekte zur Langzeittherapie   ......................................................  213\n16   Lunge  ............................................................................................................................  215\n16.1   Chronisch-obstruktive Lungenerkrankung (COPD)   .................................  216\n16.1.1   Beschwerdebild   ................................................................................................................  216\n16.1.2   Medikament\u00f6se Therapie   ...........................................................................................  217\n16.1.3   Nichtmedikament\u00f6se Therapie  ...............................................................................  220\n16.2   Sarkoidose   ..........................................................................................................................  221\n16.2.1   Symptomatik und Verlauf   ..........................................................................................  222\n16.2.2   Medikament\u00f6se Therapie   ...........................................................................................  222\n16.2.3   Nichtmedikament\u00f6se Therapie  ...............................................................................  223\n16.3   Allergische Atemwegserkrankungen   ................................................................  224\n16.3.1   Formen allergischer Atemwegserkrankungen   ...............................................  224\n16.3.2   Medikament\u00f6se Therapie   ...........................................................................................  224\n16.3.3   Allgemeine Therapie  ......................................................................................................  227\n16.4   Pneumonie   .........................................................................................................................  227\n16.4.1   Medikament\u00f6se Therapie   ...........................................................................................  227\n16.4.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  229\n17   Herz   ...............................................................................................................................  231\n17.1   Allgemeine Therapie  ....................................................................................................  233\n17.2   Herzinfarkt   ..........................................................................................................................  234\n17.2.1   \u00c4u\u00dfere Anwendungen   .................................................................................................  234\n17.2.2   Parenterale Therapie   .....................................................................................................  234\n17.3   Hypertensive Herzkrankheit   ..................................................................................  235\n17.3.1   Perorale und parenterale Therapie   ......................................................................  235Inhaltsverzeichnis XVI\n17.4   Herzrhythmusst\u00f6rungen   ...........................................................................................  235\n17.4.1   Tachykarde Herzrhythmusst\u00f6rungen   ..................................................................  236\n17.4.2   Sinusbradykardien   ..........................................................................................................  237\n17.4.3   Kardiale Palpitationen   .................................................................................................  237\n17.5   Klappenvitien   ...................................................................................................................  237\n17.6   Cor pulmonale   ..................................................................................................................  238\n17.6.1   Akutes Cor pulmonale  ...................................................................................................  238\n17.6.2   Chronisches Cor pulmonale   .......................................................................................  238\n17.7   Perikarditis   .........................................................................................................................  239\n17.7.1   Eitrige Perikarditis   ...........................................................................................................  239\n17.8   Koronare Herzkrankheit (KHK)   ..............................................................................  240\n17.8.1   Konstitutionsaspekte   ....................................................................................................  240\n17.8.2   Risikofaktoren  ....................................................................................................................  241\n17.8.3   Integrative Therapie der KHK   ...................................................................................  241\n17.8.4   Medikament\u00f6se Therapie   ...........................................................................................  243\n17.9   Herzinsuffizienz   ..............................................................................................................  247\n17.9.1   Medikament\u00f6se Therapie   ...........................................................................................  248\n18   Kreislauf   .....................................................................................................................  250\n18.1   Arterielle Hypertonie   ...................................................................................................  251\n18.1.1   Medikament\u00f6se Therapie   ...........................................................................................  251\n18.1.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  254\n18.1.3   Ern\u00e4hrungstherapie   .......................................................................................................  255\n18.1.4   Bewegung   ............................................................................................................................  256\n18.1.5   Innere Aufgabenstellung   ............................................................................................  256\n19   Venen   ...........................................................................................................................  260\n19.1   Chronisch-ven\u00f6se Insuffizienz   ............................................................................  261\n19.1.1   Phlebothrombose   ...........................................................................................................  262\n19.1.2   Thrombophlebitis   ............................................................................................................  263\n19.1.3   Ulcus cruris   ..........................................................................................................................  264\n19.1.4   Periphere \u00d6deme   .............................................................................................................  265\n19.1.5   Venopathien   .......................................................................................................................  265\n20   Blut   ................................................................................................................................  267\n20.1   Blutgef\u00e4\u00dfsystem   .............................................................................................................  268\n20.1.1   Arteriosklerose   ..................................................................................................................  268\n20.1.2   Periphere arterielle Verschlusskrankheit   .........................................................  271\n20.1.3   Zerebrovaskul\u00e4re Insuffizienz und Schlaganfall   ..........................................  272\n20.2   Vaskulitiden   .......................................................................................................................  273\n20.2.1   Zur Dreigliederung der Gef\u00e4\u00dforganisation  ......................................................  274Inhaltsverzeichnis XVII\n20.2.2   Riesenzellarteriitis und Polymyalgia rheumatica   .......................................  274\n20.2.3   Polyarteriitis nodosa (PAN), Morbus Wegener und \n Churg-Strauss-Syndrom (CSS)   ..................................................................................  275\n20.2.4   Medikament\u00f6se Therapie   ...........................................................................................  275\n20.3   An\u00e4mie   ..................................................................................................................................  276\n20.3.1   Allgemeine Therapie  ......................................................................................................  277\n20.3.2   Medikament\u00f6se Therapie   ...........................................................................................  277\n20.3.3   Therapeutische Sprachgestaltung   .........................................................................  278\n21   Lymphe   .......................................................................................................................  280\n21.1   Lymphome   ..........................................................................................................................  282\n21.1.1   Non-Hodgkin-Lymphome   .........................................................................................  282\n21.1.2   Therapie der B-Symptomatik  ...................................................................................  285\n21.1.3   Heileurythmie und k\u00fcnstlerische Therapien   .................................................  286\n21.2   Plasmozytom   .....................................................................................................................  287\n21.2.1   Medikament\u00f6se Therapie   ...........................................................................................  287\n21.3   Systemische Leichtkettenamyloidose   ..............................................................  288\n21.3.1   Medikament\u00f6se Therapie   ...........................................................................................  288\n22   Allergischer Formenkreis   .............................................................................  291\n22.1   Allgemeine Therapie  ....................................................................................................  292\n22.2   Heuschnupfen und Pollinose   ................................................................................  293\n22.2.1   Prophylaktische Therapie   ...........................................................................................  293\n22.2.2   Akuttherapie   .......................................................................................................................  294\n22.3   Neurodermitis   ..................................................................................................................  294\n22.3.1   Allgemeine Therapie  ......................................................................................................  294\n22.3.2   Spezielle Therapie   ...........................................................................................................  295\n23   Essst\u00f6rungen  ..........................................................................................................  298\n23.1   Anorexie und Bulimie   .................................................................................................  300\n23.1.1   Allgemeine Gesichtspunkte zur Pathologie   ....................................................  300\n23.1.2   Allgemeine Gesichtspunkte zur Menschenkunde   .......................................  301\n23.1.3   Allgemeine Therapieziele   ...........................................................................................  301\n23.1.4   Medikament\u00f6se Therapie und \u00c4u\u00dfere Anwendungen   ............................  302\n24   Speiser\u00f6hre   .............................................................................................................  305\n24.1   Globussyndrom   ...............................................................................................................  306\n24.2   Diffuser Oesophagospasmus   ..................................................................................  306\n24.3   Refluxoesophagitis   .......................................................................................................  306Inhaltsverzeichnis XVIII\n25   Magen-Darm   ..........................................................................................................  308\n25.1   Appetitlosigkeit und V\u00f6llegef\u00fchl   ........................................................................  310\n25.1.1   Dyspepsie   .............................................................................................................................  310\n25.2   Chronische Gastritis   .....................................................................................................  310\n25.2.1   Wesensgliederwirksamkeit bei der chronischen  \nTyp-A- und Typ-B-Gastritis   ......................................................................................  311\n25.2.2   Medikament\u00f6se Therapie bei chronischer Typ-A-Gastritis   ...................  311\n25.2.3   Medikament\u00f6se Therapie bei chronischer Typ-B-Gastritis   ..................  313\n25.2.4   \u00c4u\u00dfere Anwendungen bei chronischer Typ-B-Gastritis   .........................  314\n25.3   Akute Gastritis   ..................................................................................................................  314\n25.3.1   Medikament\u00f6se Therapie   ...........................................................................................  315\n25.4   Akute Gastroenteritis   ..................................................................................................  316\n25.5   Reizdarmsyndrom/Colon irritabile   ....................................................................  316\n25.6   Chronisch-entz\u00fcndliche Darmerkrankungen  ............................................  317\n25.6.1   Morbus Crohn   .....................................................................................................................  318\n25.6.2   Colitis ulcerosa   ..................................................................................................................  319\n25.6.3   Mikroskopische Colitis: lymphozyt\u00e4re und kollagene Colitis   ...............  322\n25.7   Diarrh\u00f6   ..................................................................................................................................  322\n25.7.1   Medikament\u00f6se Therapie   ...........................................................................................  323\n25.8   Obstipation   .........................................................................................................................  324\n25.8.1   Allgemeine Therapie  ......................................................................................................  324\n25.8.2   Medikament\u00f6se Therapie   ...........................................................................................  325\n25.9   Erkrankungen des Anorektums  ............................................................................  325\n25.9.1   Medikament\u00f6se Therapie   ...........................................................................................  326\n25.10   Divertikulitis   ......................................................................................................................  326\n25.10.1   Medikament\u00f6se Therapie   ...........................................................................................  326\n26   Leber   .............................................................................................................................  329\n26.1   Leitgedanke, Wesensgliederwirksamkeit und Therapieansatz   .... 330\n26.1.1   Wesensgliederwirken in der Leber   .......................................................................  331\n26.1.2   St\u00e4rkung der Leberfunktion durch Willensschulung   .................................  332\n26.2   Akute und chronische Hepatitis   ..........................................................................  333\n26.2.1   Symptomatik   ......................................................................................................................  334\n26.2.2   Medikament\u00f6se Therapie der akuten Hepatitis   ...........................................  334\n26.2.3   \u00c4u\u00dfere Anwendungen bei akuter Hepatitis   ...................................................  335\n26.2.4   Medikament\u00f6se Therapie der chronischen Hepatitis B und C   ............  335\n26.2.5   \u00c4u\u00dfere Anwendungen bei chronischer Hepatitis B und C   ....................  336Inhaltsverzeichnis XIX\n26.3   Hepatozellul\u00e4res Karzinom   .....................................................................................  336\n26.3.1   Medikament\u00f6se Therapie   ...........................................................................................  337\n26.4   Leberzirrhose   ....................................................................................................................  337\n26.4.1   Wesensgliederwirksamkeit bei der Leberzirrhose   ......................................  338\n26.4.2   Medikament\u00f6se Therapie   ...........................................................................................  338\n26.4.3   \u00c4u\u00dfere Anwendungen   .................................................................................................  340\n26.5   Steatosis hepatis und Steatohepatitis (NASH)   ...........................................  341\n26.5.1   Allgemeine Therapie  ......................................................................................................  341\n26.5.2   Medikament\u00f6se Therapie   ...........................................................................................  341\n27   Galle   ..............................................................................................................................  344\n27.1   Allgemeine Therapieempfehlungen bei Erkrankungen des  \nGallensystems   ..................................................................................................................  346\n27.2   Morbus Meulengracht   .................................................................................................  347\n27.2.1   Medikament\u00f6se Therapie   ...........................................................................................  347\n27.2.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  347\n27.3   Dyskinesien der Gallenorganisation   ................................................................  348\n27.3.1   Medikament\u00f6se Therapie   ...........................................................................................  348\n27.4   Cholelithiasis   ....................................................................................................................  349\n27.4.1   Medikament\u00f6se Therapie   ...........................................................................................  349\n27.5   Akute Cholecystitis   ........................................................................................................  350\n27.5.1   Medikament\u00f6se Therapie   ...........................................................................................  350\n27.6   Cholangiol\u00e4res Karzinom und Gallenblasenkarzinom   .......................  351\n27.6.1   Medikament\u00f6se Therapie   ...........................................................................................  351\n27.7   Prim\u00e4r bili\u00e4re Zirrhose und prim\u00e4r sklerosierende Cholangitis   ... 351\n27.7.1   Medikament\u00f6se Therapie   ...........................................................................................  352\n28   Bauchspeicheldr\u00fcse   .........................................................................................  354\n28.1   Akute und chronische Pankreatitis   ...................................................................  356\n28.1.1   Medikament\u00f6se Therapie   ...........................................................................................  356\n28.2   Diabetes mellitus   ...........................................................................................................  357\n28.2.1   Das Wirken der Wesensglieder beim Typ-1-Diabetes   ..............................  358\n28.2.2   Diabetes mellitus Typ 2 und das Metabolische Syndrom   .......................  359\n28.2.3   Seelische Ph\u00e4nomenologie beim Metabolischen Syndrom   ..................  359\n28.2.4   Allgemeine Gesichtspunkte zur Therapie des Diabetes mellitus  \n(Typ 1 und Typ 2)   ..............................................................................................................  359\n28.2.5   Medikament\u00f6se Therapie   ...........................................................................................  360\n28.2.6   Heileurythmie   ...................................................................................................................  365\n28.2.7   Therapeutisches Plastizieren   ....................................................................................  365Inhaltsverzeichnis XX\n28.2.8   Therapeutische Sprachgestaltung bei Diabetes mellitus  ........................  366\n28.2.9   Individuelle Aufgabenstellung, Biografiearbeit, therapeutisches \nGespr\u00e4ch  und Selbstschulung   .................................................................................  366\n28.3   Krankheitsmanifestationen und Folgeerkrankungen   .........................  368\n28.3.1   Adipositas   .............................................................................................................................  368\n28.3.2   Demenzielle Syndrome bei Diabetes  ...................................................................  370\n28.3.3   Das diabetische Fu\u00dfsyndrom   ...................................................................................  373\n28.3.4   Gastrointestinale Motilit\u00e4tsst\u00f6rungen   ...............................................................  376\n28.3.5   Diabetische Polyneuropathie   ..................................................................................  377\n28.3.6   Diabetische Nephropathie   .........................................................................................  379\n29   Nieren   ..........................................................................................................................  384\n29.1   Die gest\u00f6rte Nierenfunktion: Niereninsuffizienz und Sklerose   .... 385\n29.1.1   Allgemeine Therapie  ......................................................................................................  386\n29.1.2   Heileurythmie   ...................................................................................................................  387\n29.2   Glomerulonephritis   ......................................................................................................  388\n29.2.1   Medikament\u00f6se Therapie   ...........................................................................................  388\n29.2.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  389\n29.3   Nephrolithiasis   ................................................................................................................  390\n29.3.1   Medikament\u00f6se Therapie   ...........................................................................................  390\n30   Ableitende Harnwege   .....................................................................................  392\n30.1   Harnwegsinfekt   ...............................................................................................................  393\n30.1.1   Medikament\u00f6se Therapie   ...........................................................................................  393\n30.1.2   Nichtmedikament\u00f6se Therapie  ...............................................................................  394\n31   Blase   .............................................................................................................................  395\n31.1   Harninkontinenz   ............................................................................................................  396\n31.1.1   Medikament\u00f6se Therapie   ...........................................................................................  396\n31.1.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  397\n32   M\u00e4nnliche Geschlechtsorgane   ................................................................  398\n32.1   Akute und chronische Prostatitis   .......................................................................  399\n32.1.1   Medikament\u00f6se Therapie   ...........................................................................................  399\n32.2   Benigne Prostatahyperplasie und Prostatakarzinom   ..........................  400\n32.2.1   Medikament\u00f6se Therapie   ...........................................................................................  400\n32.2.2   Seelisch-geistige Begleitbehandlung   ................................................................  401\n33   Weibliche Geschlechtsorgane   ..................................................................  402\n33.1   Menstruationsst\u00f6rungen   ..........................................................................................  403\n33.2   Chronisch unspezifische Unterleibsschmerzen, Kr\u00e4mpfe   .................  404Inhaltsverzeichnis XXI\n33.3   Vaginale Infektion   .........................................................................................................  405\n33.3.1   Bakterielle Kolpitis   .........................................................................................................  406\n33.3.2   Aminkolpitis (Bakterielle Vaginose)   .....................................................................  407\n33.3.3  Rezidivierende Kolpitis   ................................................................................................  407\n33.3.4   Atrophische Kolpitis   .......................................................................................................  408\n33.3.5   Soorkolpitis und Vulvitis   .............................................................................................  408\n33.4   Kinderwunsch   ..................................................................................................................  408\n33.4.1   Prim\u00e4re/Sekund\u00e4re Sterilit\u00e4t   ....................................................................................  409\n33.4.2   Vor- und Nachbetreuung assistierter Konzeptionen   ................................  409\n33.4.3   Habituelle Aborte   ............................................................................................................  409\n33.5   Androgenisierungserscheinungen (Hyperandrogen\u00e4mie, \n Hypertrichose, Hirsutismus, Virilisierung)   ...................................................  410\n33.6   Gutartige und entz\u00fcndliche Erkrankungen   ................................................  410\n33.7   Erkrankungen des \u00e4u\u00dferen Genitale   ...............................................................  411\n33.7.1   Condylome   ...........................................................................................................................  411\n33.7.2   Herpes genitales   ..............................................................................................................  411\n33.7.3   Vulvitis   ....................................................................................................................................  412\n33.7.4   Bartholinitis   ........................................................................................................................  412\n33.7.5   Lichen sclerosus et atrophicans/Kraurosis   .......................................................  412\n33.7.6   Mykose  ....................................................................................................................................  413\n33.7.7   Sexuell \u00fcbertragbare Krankheiten (Sexually Transmitted  \nDiseases = STD)   ..................................................................................................................  413\n33.7.8   Ektoparasit\u00e4re Erkrankungen   ..................................................................................  413\n33.8   Erkrankungen des inneren Genitale   ................................................................  413\n33.8.1   Ektopie   ...................................................................................................................................  413\n33.8.2   Ovula Nabothi   ....................................................................................................................  413\n33.8.3   Zervizitis   ................................................................................................................................  413\n33.8.4   Polypen   ..................................................................................................................................  414\n33.8.5   Endometriumhyperplasie   ..........................................................................................  415\n33.8.6   Myome   ....................................................................................................................................  415\n33.8.7   Endometritis/Myometritis   ..........................................................................................  416\n33.9   Erkrankungen der Adnexe   .......................................................................................  416\n33.9.1   Extrauteringravidit\u00e4t   .....................................................................................................  416\n33.9.2   Adnexitis   ...............................................................................................................................  416\n33.9.3   Tubo-Ovarialabszess   ......................................................................................................  417\n33.9.4   Ovarialzysten   ......................................................................................................................  417\n33.9.5   Endometriose   .....................................................................................................................  418\n33.10   Gutartige Mammaerkrankungen   ........................................................................  419\n33.10.1   Mastodynie   ..........................................................................................................................  420\n33.10.2   Mastopathie   ........................................................................................................................  420Inhaltsverzeichnis XXII\n33.10.3   Fibr\u00f6se/Fibrozystische Mastopathie   .....................................................................  420\n33.10.4   Benigne Tumoren   ............................................................................................................  420\n33.10.5   Mastitis puerperalis   .......................................................................................................  421\n33.10.6   Sexuelle Traumatisierungen   .....................................................................................  421\n33.10.7   Komplement\u00e4re Therapie zur seelischen Unterst\u00fctzung   .......................  421\n33.11   Gyn\u00e4kologische Onkologie   ......................................................................................  421\n34   Gelenke und Bindegewebe   .......................................................................  423\n34.1   Chronisches Gelenkrheuma/Chronische Polyarthritis   ..........................  424\n34.1.1   Anthroposophische Basistherapie   ........................................................................  424\n34.1.2   Allgemeine Therapie  ......................................................................................................  425\n34.1.3   Tierische Arzneimittel   ...................................................................................................  426\n34.1.4   Pflanzliche Arzneimittel   ..............................................................................................  427\n34.1.5   \u00c4u\u00dfere Anwendungen   .................................................................................................  430\n34.1.6   Mineralische und metallische Substanzen zur St\u00e4rkung der \n Ich-Organisation   ..............................................................................................................  431\n34.1.7   Einsatz konventioneller Pharmaka/Einsatz von Corticoiden   ................  432\n34.2   Fingerpolyarthrose   .......................................................................................................  433\n34.2.1   Allgemeine Therapie  ......................................................................................................  434\n34.3   H\u00fcft- und Kniegelenksarthrose   ..........................................................................  435\n34.3.1   Allgemeine Therapie  ......................................................................................................  436\n34.3.2   Spezielle Therapie   ...........................................................................................................  436\n34.4   Reaktive Arthritiden   ....................................................................................................  437\n34.4.1   Medikament\u00f6se Therapie   ...........................................................................................  439\n34.5   Gicht   ........................................................................................................................................  439\n34.5.1   Medikament\u00f6se Therapie   ...........................................................................................  439\n34.6   Periarthritis humeroscapularis   ............................................................................  440\n34.6.1   Medikament\u00f6se Therapie   ...........................................................................................  440\n34.7   Enthesiopathie und Tendovaginitis   .................................................................  441\n34.7.1   Medikament\u00f6se Therapie   ...........................................................................................  441\n34.7.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  442\n34.8   Sj\u00f6gren-Syndrom   ...........................................................................................................  442\n34.8.1   Das Wirken der Wesensglieder beim Sj\u00f6gren-Syndrom   ..........................  443\n34.8.2   Medikament\u00f6se Therapie   ...........................................................................................  443\n34.9   Sklerodermie und Lupus erythematodes   .....................................................  444\n34.9.1   Medikament\u00f6se Therapie bei Sklerodermie   ...................................................  445\n34.9.2   Medikament\u00f6se Therapie bei Lupus erythematodes   ................................  446Inhaltsverzeichnis XXIII\n35   Wirbels\u00e4ule   .............................................................................................................  448\n35.1   Diskusprolaps   ...................................................................................................................  450\n35.1.1   Medikament\u00f6se Therapie   ...........................................................................................  450\n35.1.2   Nichtmedikament\u00f6se Therapie  ...............................................................................  452\n35.2   Morbus Bechterew   ........................................................................................................  452\n35.2.1   Medikament\u00f6se Therapie   ...........................................................................................  453\n36   Knochen   .....................................................................................................................  455\n36.1   Osteoporose   .......................................................................................................................  456\n36.1.1   Die Wirkung der Wesensglieder in Pathologie und Therapie  \nder Osteoporose   ...............................................................................................................  456\n36.1.2   Allgemeine Therapie  ......................................................................................................  457\n36.1.3   Medikament\u00f6se Therapie   ...........................................................................................  457\n36.1.4   Krankengymnastik und Heileurythmie   .............................................................  459\n37   Muskeln   ......................................................................................................................  460\n37.1   Fibromyalgie-Syndrom   ..............................................................................................  461\n37.1.1   Medikament\u00f6se Therapie   ...........................................................................................  462\n37.1.2   Nichtmedikament\u00f6se Therapie  ...............................................................................  463\n38   Haut   ...............................................................................................................................  464\n38.1   Acne vulgaris   .....................................................................................................................  465\n38.1.1   Erscheinungsbild   .............................................................................................................  466\n38.1.2   Therapeutisches Vorgehen   .........................................................................................  467\n38.1.3   Akne und Ern\u00e4hrung   .....................................................................................................  467\n38.1.4   Medikament\u00f6se Therapie   ...........................................................................................  468\n38.1.5   Naturkosmetische Behandlung   ..............................................................................  471\n38.2   Psoriasis vulgaris   ............................................................................................................  472\n38.2.1   Assoziierte St\u00f6rungen innerer Organe   ................................................................  472\n38.2.2   Medikament\u00f6se Therapie   ...........................................................................................  473\n38.2.3   \u00c4u\u00dfere Anwendungen   .................................................................................................  477\n38.2.4   Kunsttherapie, Heileurythmie und Selbstschulung   ..................................  477\n38.2.5   Konventionelle Therapieans\u00e4tze   ...........................................................................  478\n38.3   Urtikaria   ................................................................................................................................  480\n38.3.1   Medikament\u00f6se Therapie   ...........................................................................................  481\n38.4   Leberdermatosen   ...........................................................................................................  483\n38.4.1   Zur Menschenkunde der Leberdermatosen   ....................................................  484\n38.4.2   Leberdermatosen und Erkennen ihres hepatischen Heilbedarfes   .. 485\n38.4.3   Basistherapie f\u00fcr Leber und Haut   .........................................................................  486\n38.4.4   Rosazea   ..................................................................................................................................  487\n38.4.5   Follikulitiden   ......................................................................................................................  488Inhaltsverzeichnis XXIV\n38.4.6   Seborrhoisches Ekzem   ..................................................................................................  488\n38.4.7   Pityriasis versicolor und Mykosen der Haut   ....................................................  489\n38.4.8   Analekzem   ...........................................................................................................................  490\n38.4.9   Prurigo simplex subacuta   ...........................................................................................  491\n38.4.10   Lichen ruber planus   .......................................................................................................  491\n38.4.11   Polymorphe Lichtdermatose   ....................................................................................  491\n38.4.12   Trockene, juckende Hautver\u00e4nderungen   .........................................................  492\n38.4.13   Varikosis und H\u00e4morrhoiden   ...................................................................................  492\n38.5   Neurodermitis   ..................................................................................................................  493\n38.5.1   Medikament\u00f6se Therapie   ...........................................................................................  494\n38.5.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  498\n38.5.3   Zus\u00e4tzliche Therapien   ...................................................................................................  500\n38.5.4   Milchschorf   ..........................................................................................................................  501\n38.5.5   S\u00e4uglingsekzem   ................................................................................................................  501\n38.5.6   Cheilitis sicca, periorales Ekzem und Ohrragade   .........................................  502\n38.5.7   Pytiriasis alba  .....................................................................................................................  502\n38.5.8   Lidekzem   ...............................................................................................................................  502\n38.5.9   Handekzem   .........................................................................................................................  502\n38.5.10   Geh\u00f6rgangsekzem   ..........................................................................................................  503\n38.5.11   Retroaurikul\u00e4res Ekzem   ...............................................................................................  503\n38.5.12   Brustwarzenekzem   .........................................................................................................  504\n38.5.13   Vulvaekzem   .........................................................................................................................  504\n38.5.14   Neurodermitis circumscripta   ....................................................................................  504\n38.5.15   Nummul\u00e4re Form der Neurodermitis  ..................................................................  504\n39   Schwangerschaft, Stillzeit, Wechseljahre   ......................................  508\n39.1   Blutungen in der Fr\u00fchschwangerschaft   ........................................................  509\n39.1.1   Medikament\u00f6se Therapie   ...........................................................................................  509\n39.2   Pr\u00e4eklampsie   ....................................................................................................................  510\n39.2.1   Medikament\u00f6se Therapie   ...........................................................................................  511\n39.3   \u00dcbelkeit und Hyperemesis gravidarum   .........................................................  513\n39.3.1   Medikament\u00f6se Therapie   ...........................................................................................  513\n39.4   Schwangerschaftsan\u00e4mie   ........................................................................................  513\n39.4.1   Therapie   ................................................................................................................................  514\n39.5   Vorzeitige Wehent\u00e4tigkeit   .......................................................................................  514\n39.5.1   Medikament\u00f6se Therapie   ...........................................................................................  514\n39.5.2   Begleittherapien   ..............................................................................................................  515\n39.6   Wadenkr\u00e4mpfe in der Schwangerschaft   .......................................................  515\n39.6.1   Therapie   ................................................................................................................................  515Inhaltsverzeichnis XXV\n39.7   Milchstau/Mastitis   .........................................................................................................  516\n39.7.1   \u00c4u\u00dfere Anwendungen bei Milchstau  ..................................................................  516\n39.7.2   Perorale Therapie  .............................................................................................................  516\n39.7.3   Therapie bei Mastitis   .....................................................................................................  517\n39.8   Wechseljahre   .....................................................................................................................  517\n39.8.1   Therapie   ................................................................................................................................  518\n39.8.2   Descensus uteri   .................................................................................................................  519\n39.8.3   Zystitis   .....................................................................................................................................  520\n40   Onkologie   ..................................................................................................................  521\n40.1   Allgemeine Gesichtspunkte   ...................................................................................  522\n40.1.1   Allgemeine Therapie  ......................................................................................................  522\n40.1.2   Grundprinzipien der Misteltherapie   ...................................................................  524\n40.2   Bronchialkarzinom   .......................................................................................................  528\n40.2.1   Therapie   ................................................................................................................................  528\n40.3   Kolorektales Karzinom   ...............................................................................................  530\n40.3.1   Chirurgische und chemotherapeutische Therapie   ......................................  530\n40.3.2   Medikament\u00f6se Therapie   ...........................................................................................  530\n40.3.3   Nichtmedikament\u00f6se Therapie  ...............................................................................  532\n40.4   Mammakarzinom   ...........................................................................................................  533\n40.4.1   Therapie   ................................................................................................................................  533\n40.5   Prostatakarzinom   ..........................................................................................................  535\n40.5.1   Pr\u00e4vention  ............................................................................................................................  535\n40.5.2   Therapie   ................................................................................................................................  535\n40.6   Malignes Melanom   .......................................................................................................  536\n40.6.1   Therapie   ................................................................................................................................  537\n40.7   Inoperables Pankreaskarzinom   ...........................................................................  538\n40.7.1   Einleitung   .............................................................................................................................  538\n40.7.2   Das Adenokarzinom des Pankreas (PCa)   ............................................................  539\n40.7.3   Therapie   ................................................................................................................................  539\n40.8   Pleuramesotheliom   ......................................................................................................  543\n40.8.1   Medikament\u00f6se Therapie   ...........................................................................................  544\n40.9   Magenkarzinom   ..............................................................................................................  544\n40.9.1   Medikament\u00f6se Therapie   ...........................................................................................  545\n40.10   Harnblasenkarzinom   ...................................................................................................  546\n40.10.1   Das Wirken der Wesensglieder beim Harnblasenkarzinom   ..................  547\n40.10.2   Medikament\u00f6se Therapie   ...........................................................................................  547Inhaltsverzeichnis XXVI\n40.11   Ovarialkarzinom  ..............................................................................................................  547\n40.11.1   Medikament\u00f6se Therapie   ...........................................................................................  548\n40.12   Therapeutische Begleitung w\u00e4hrend der Chemotherapie   ...............  549\n40.12.1   Medikament\u00f6se Begleittherapie   ...........................................................................  549\n40.12.2   Nichtmedikament\u00f6se Begleittherapie   ...............................................................  550\n40.13   Tumorassoziierte Beschwerden und Krankheitsbilder   .......................  551\n40.13.1   Kachexie, Appetitlosigkeit, \u00dcbelkeit   ...................................................................  551\n40.13.2   Peritonealkarzinose   .......................................................................................................  554\n40.13.3   Tumorassoziiertes Fieber   ............................................................................................  554\n40.13.4   Mukositis, radiogene Schleimhautsch\u00e4den, exulzerierende  \nTumoren   ................................................................................................................................  555\n40.13.5   Anasarka und Aszites im Rahmen der fortgeschrittenen \n Krebserkrankung   ..............................................................................................................  556\n40.13.6   Haut- und Schleimhautblutungen   ......................................................................  558\n40.13.7   Das Cancer-Fatigue-Syndrom   ..................................................................................  559\n40.13.8   Krebskrankheit und Schlaf   ........................................................................................  561\n40.13.9   Depression   ...........................................................................................................................  561\n40.13.10   Metastasierung   .................................................................................................................  562\n40.14   Perioperative Therapie und Narkosebegleitung   ......................................  567\n40.14.1   Medikament\u00f6se Therapie   ...........................................................................................  567\n41   Chirurgie   ....................................................................................................................  576\n41.1   Perioperative Behandlung   ......................................................................................  577\n41.1.1   Narkose   ..................................................................................................................................  577\n41.1.2   Wundheilung   .....................................................................................................................  581\n42   P\u00e4diatrie   ....................................................................................................................  584\n42.1   Infektabwehrschw\u00e4che beim Kind   ...................................................................  585\n42.1.1   Symptomatik   ......................................................................................................................  585\n42.1.2   Therapien   .............................................................................................................................  585\n42.2   Pneumonie beim Kind   ...............................................................................................  587\n42.2.1   Symptomatik   ......................................................................................................................  587\n42.2.2   Therapien   .............................................................................................................................  588\n42.3   Erkrankung des Magen-Darm-Trakts bei Kindern   .................................  590\n42.3.1   Durchfall   ................................................................................................................................  590\n42.3.2   Erbrechen   .............................................................................................................................  591\n42.3.3   Obstipation   ..........................................................................................................................  592\n42.4   Schlafst\u00f6rungen bei Kindern  .................................................................................  593\n42.4.1   Allgemeine Therapie  ......................................................................................................  594\n42.4.2   Medikament\u00f6se Therapie   ...........................................................................................  594\n42.4.3   \u00c4u\u00dfere Anwendungen   .................................................................................................  595Inhaltsverzeichnis XXVII\n42.5   Retentio testis   ..................................................................................................................  596\n42.5.1   Medikament\u00f6se Therapie   ...........................................................................................  596\n42.6   Phimose   ................................................................................................................................  597\n43   Neonatologie   .........................................................................................................  598\n43.1   Allgemeine Therapie  ....................................................................................................  599\n43.1.1   W\u00e4rme und allgemeine Unruhe   ............................................................................  599\n43.1.2   Atmung, Anpassungsst\u00f6rung und Atemwegsinfekte   ................................  600\n43.1.3   Zirkulation und vegetative Selbstregulation, Traumafolgen   ................  601\n43.2   Ern\u00e4hrung und Verdauung, Essst\u00f6rungen   ...................................................  601\n43.3   Ikterus neonatorum   .....................................................................................................  602\n44   Kinderpsychiatrie   ...............................................................................................  604\n44.1   Psychotrauma   ...................................................................................................................  605\n44.1.1   Epidemiologie, Symptomatik und Verlauf   .......................................................  606\n44.1.2   Grundlegende Traumatherapie   ..............................................................................  606\n44.1.3   Medikament\u00f6se Therapie   ...........................................................................................  608\n44.2   Aufmerksamkeitsdefizit-Hyperaktivit\u00e4tsst\u00f6rung/ADHS   .....................  610\n44.2.1   Allgemeine Symptomatik   ...........................................................................................  611\n44.2.2   Gesichtspunkte zur multifaktoriellen \u00c4tiologie   ...........................................  612\n44.2.3   Zur Epidemiologie   ...........................................................................................................  612\n44.2.4   Soziale und biografische Folgen   ............................................................................  613\n44.2.5   Allgemeine Gesichtspunkte zur p\u00e4dagogischen Behandlung   ............  613\n44.2.6   Allgemeine Gesichtspunkte zur Therapie   .........................................................  614\n44.2.7   Medikament\u00f6se Therapie   ...........................................................................................  615\n45   Psychiatrie   ................................................................................................................  619\n45.1   Angstst\u00f6rungen   ...............................................................................................................  620\n45.1.1   Systematik, Pr\u00e4valenz und Verlauf der Angstst\u00f6rungen   .........................  621\n45.1.2   Psychotherapeutische Ans\u00e4tze  ................................................................................  622\n45.1.3   Medikament\u00f6se Therapie   ...........................................................................................  622\n45.1.4   Kunsttherapie und Heileurythmie   .......................................................................  625\n45.1.5   Psychopharmakotherapie   ..........................................................................................  625\n45.2   Zwangsst\u00f6rung   ................................................................................................................  626\n45.2.1   Symptomatik und Verlauf   ..........................................................................................  626\n45.2.2   Psychotherapeutische Ans\u00e4tze  ................................................................................  627\n45.2.3   Psychopharmakotherapie   ..........................................................................................  627\n45.2.4   Medikamente und \u00c4u\u00dfere Anwendungen   ......................................................  627\n45.2.5  Kunsttherapie und Heileurythmie   .......................................................................  629\n45.3   Unipolare depressive St\u00f6rungen   .........................................................................  629\n45.3.1   Psychotherapeutische Ans\u00e4tze  ................................................................................  630Inhaltsverzeichnis XXVIII\n45.3.2   Psychopharmakotherapie   ..........................................................................................  631\n45.3.3   Medikament\u00f6se Therapie und \u00c4u\u00dfere Anwendungen   ............................  631\n45.4   Bipolare affektive St\u00f6rung   ......................................................................................  638\n45.4.1   Symptome und Verlauf   ................................................................................................  639\n45.4.2   Psychopharmakotherapie   ..........................................................................................  640\n45.4.3   Psychotherapeutische Ans\u00e4tze  ................................................................................  640\n45.4.4   Medikament\u00f6se Therapie und \u00c4u\u00dfere Anwendungen   ............................  640\n45.4.5   Kunsttherapie und Heileurythmie   .......................................................................  641\n45.5   Schizophrenien und andere psychotische St\u00f6rungen   .........................  641\n45.5.1   Psychopharmakotherapie   ..........................................................................................  643\n45.5.2   Psychotherapeutische und sozialpsychiatrische Ans\u00e4tze   ......................  643\n45.5.3   Medikament\u00f6se Therapie und \u00c4u\u00dfere Anwendungen   ............................  643\n45.5.4   Kunsttherapie und Heileurythmie   .......................................................................  645\n46   Suchttherapie   ........................................................................................................  647\n46.1   Alkoholabh\u00e4ngigkeit   ...................................................................................................  649\n46.1.1   Akuttherapie bei Erwachsenen   ..............................................................................  651\n46.1.2   Medikament\u00f6se Symptomtherapie   ......................................................................  651\n46.1.3   Qualifizierter Entzug   ......................................................................................................  652\n46.1.4   Therapiema\u00dfnahmen bei Kindern und Jugendlichen   ............................  652\n46.1.5   Postakutbehandlung   ....................................................................................................  652\n46.1.6   Nachsorge   .............................................................................................................................  653\n46.2   Biodrogen-Abh\u00e4ngigkeit   .........................................................................................  654\n46.2.1   Symptomatik   ......................................................................................................................  655\n46.2.2   Medikament\u00f6se Therapie   ...........................................................................................  656\n46.2.3   \u00c4u\u00dfere Anwendungen und weitere Therapien   ............................................  656\n47   Geriatrie   .....................................................................................................................  659\n47.1   Demenzerkrankungen   ................................................................................................  661\n47.1.1   Allgemeine medikament\u00f6se Therapie   ...............................................................  662\n47.1.2   Anthroposophische Therapie   ...................................................................................  662\n47.1.3   Nichtmedikament\u00f6se Therapie  ...............................................................................  663\n48   Schmerztherapie  .................................................................................................  666\n48.1   Medikament\u00f6se Therapie   ........................................................................................  667\n48.1.1   Klassische Analgetika in der Schmerztherapie   .............................................  667\n48.1.2   Therapiekonzepte in der Schmerztherapie   .....................................................  669\n49   Pr\u00e4vention  ................................................................................................................  675\n49.1   Schlafhygiene/Schlafst\u00f6rungen   ...........................................................................  676\n49.1.1   Allgemeine Therapie  ......................................................................................................  676\n49.1.2   Medikament\u00f6se Therapie   ...........................................................................................  677Inhaltsverzeichnis XXIX\n49.1.3   \u00c4u\u00dfere Anwendungen   .................................................................................................  679\n49.1.4   Schlafst\u00f6rungen beim Restless-Legs-Syndrom   ............................................  679\n49.1.5   Schlafst\u00f6rungen im Rahmen depressiver Syndrome   ................................  680\n49.1.6   Schlafst\u00f6rungen im Rahmen weiterer Erkrankungen   ..............................  681\n50   Rehabilitation   .......................................................................................................  682\n50.1   Natur mit heilkr\u00e4ftiger Wirkung   .........................................................................  683\n50.2   Nahrungsmittel als Heilmittel   ..............................................................................  683\n50.3   Kunst und Eurythmie als Heilmittel   .................................................................  684\n50.4   Therapeutische Gespr\u00e4che als Heilmittel   .....................................................  684\n50.5   Pharmakotherapie   ........................................................................................................  684\n50.5.1   \u00c4u\u00dfere Anwendungen   .................................................................................................  685\n50.5.2   Injektionspr\u00e4parate   .......................................................................................................  686\n50.5.3   Orale Gabe von Medikamenten   ..............................................................................  687\n50.5.4   Misteltherapie   ...................................................................................................................  688\n50.5.5   Behandlung mit Organpr\u00e4paraten   .......................................................................  688\n50.6   Verantwortungsvolle Zusammenarbeit   ..........................................................  689\n51   Palliativmedizin   ..................................................................................................  691\n51.1   Therapeutische Begleitung des sterbenden Menschen   .....................  692\n51.1.1   Drei Wege \u00fcber die Todesschwelle   .......................................................................  692\n51.1.2   Der Heilbedarf des sterbenden Menschen   ......................................................  693\n51.1.3   Fieber in der Sterbephase   ..........................................................................................  694\n51.1.4   Angst und Unruhe   ...........................................................................................................  695\n51.1.5   \u00dcbelkeit   .................................................................................................................................  697\n51.1.6   Obstipation   ..........................................................................................................................  698\n51.1.7   Singultus   ...............................................................................................................................  698\n51.1.8   Dyspnoe   .................................................................................................................................  699\n51.1.9   Pruritus   ..................................................................................................................................  700\n51.1.10   Blutung   ..................................................................................................................................  700\n51.1.11   Arzneimittel im Sterbeprozess   ................................................................................  701\n51.1.12   \u00c4u\u00dfere Anwendungen in der Krankenpflege   ................................................  702\n51.1.13   Kunsttherapien und Heileurythmie   ....................................................................  703\n52   Covid-19   ....................................................................................................................  705\n52.1   Virus und Mensch \u2013 ein Dialog   ............................................................................  706\n52.2   Infektion und Disposition   .......................................................................................  707\n52.3   Pr\u00e4vention   ..........................................................................................................................  708\n52.4   Krankheitsbild   .................................................................................................................  709\n52.4.1   Grippales Stadium   ..........................................................................................................  709\n52.4.2   Covid-19-Pneumonie   ..................................................................................................  713\n52.4.3   Atemnotsyndrom (ARDS), Sepsis und Multiorganversagen   ...................  716Inhaltsverzeichnis XXX\n52.5   Rekonvaleszenz   ...............................................................................................................  718\n52.5.1   Medikament\u00f6se Therapie   ...........................................................................................  718\n52.5.2   \u00c4u\u00dfere Anwendungen   .................................................................................................  719\nTEIL C  ANHANG\nAdressen   .....................................................................................................................................................  725\nBildnachweis   ............................................................................................................................................  730\nSachregister   ..............................................................................................................................................  733\nDie Herausgeber   .....................................................................................................................................  769\nDie Autoren   ...............................................................................................................................................  771", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}